Distinguishing ENKTL and ALCL coexpressing CD56 and CD30 is not of simple academic interest, but has great clinical relevance owing to the different therapeutic approaches and prognoses of these two diseases. The gene discussed is NCAM1; the disease is anaplastic large cell lymphoma.